Mucosal immunity to bacteria

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 783-797

  Holmgren, Jan ^a   Svennerholm, Ann Mari ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847318269     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50046-2     Document Type: Chapter

References (127)

1. Agace W.W., Svanborg C. Mucosal immunity in the urinary system. MucosalVaccines 1996, 389-402. Academic Press, London. H. Kiyono, P.L. Ogra, J.R. McGhee (Eds.).
2. Archimandritis A., Sougioultzis S., Foukas P.G., Tzivras M., Davaris P., Moutsopoulos H.M. Expression of HLA-DR, costimulatory molecules B7-1, B7-2, intercellular adhesion molecule-1 (ICAM-1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis: influence of H. pylori eradication. Clin. Exp. Immunol. 2000, 119:464-471.
3. + T cells. J. Immunol. 2002, 169:3232-3241.
4. Bäckhed F., Rokbi B., Torstensson E., Zhao Y., Nilsson C., Seguin D., Normark S., Buchan AM, Richter-Dahlfors A. Gastric mucosal recognition of Helicobacter pylori is independent of toll-like receptor 4. J. Infect. Dis. 2003, 187:829-836.
5. Bals R. Epithelial anti-microbial peptides in host defence against infection. Respir. Res. 2000, 1:141-150.
6. Bao S., Beagley K.W., France M.P., Shen J., Husband A.J. Interferon-gamma plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology 2000, 99:464-472.
7. Basset C., Holton J., O'Mahony R., Roitt I. Innate immunity and pathogen-host interaction. Vaccine 2003, 21:12-23.
8. Bengoechea J.A., Skurnik M. Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic anti-microbial peptides in Yersinia. Mol. Microbiol. 2000, 37:67-80.
9. Bock K., Breimer M.E., Brignole A., Hansson G.C., Karlsson K.A., Larson G., Leffler H., Samuelsson B.E., Strömberg N., Svanborg-Edén C., Thurin J. Specificity of binding of a strain of uropathogenic Escherichia coli to Galα1→4Gal-containing glycosphingolipids. J. Biol. Chem. 1985, 260:8545-8551.
10. Borén T., Falk P., Roth K.A., Larsson G., Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993, 262(5141):1892-1895.
11. Borody T., Ren Z., Pang G., Clancy R. Impaired host immunity contributes to Helicobacter pylori eradication failure. Am. J. Gastroenterol. 2002, 97:3032-3037.
12. Cain T.K., Rank R.G. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 1995, 63:1784-1789.
13. Cohen D., Ashkenazi S., Green M.S., Gdalevich M., Robin G., Slepon R., Yavzori M., Orr N., Block C., Ashkenazi I., Shemer J., Taylor D.N., Hale T.L., Sadoff J.C., Pavliakova D., Schneerson R., Robbins J.B. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet 1997, 349:155-159.
14. Cong Y., Weaver C.T., Lazenby A., Elson C.O. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 2002, 169:6112-6119.
15. Crabtree J.E., Farmery S.M., Lindley I.J., Figura N., Peichl P., Tompkins D.S. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J. Clin. Pathol. 1994, 47:945-950.
16. Cutter D., Mason K.W., Howell A.P., Fink D.L., Green B.A., St Geme J.W. Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice. J. Infect. Dis. 2002, 186:1115-1121.
17. Donnenberg M.S., Kaper J.B., Finlay B.B. Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol. 1997, 5(3):109-114.
18. Dodson K.W., Pinkner J.S., Rose T., Magnusson G., Hultgren S.J., Waksman G. Structural basis of the interaction of the pyelonephritic E. coli adhesion to its human kidney receptor. Cell 2001, 105:733-743.
19. Duchmann R., Schmitt E., Knolle P., Meyer zum Büschenfelde K.-H., Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 1996, 26:934-938.
20. Dwinell M.B., Eckmann L., Leopard J.D., Varki N.M., Kagnoff M.F. Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 1999, 117:359-367.
21. Dybing J.K., Walters N., Pascual D.W. Role of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections Infect. Immun. 1999, 67:6242-6248.
22. Eckmann L., Kagnoff M.F. Cytokines in host defense against Salmonella. Microbes Infect. 2001, 3:1191-1200.
23. Ejima K., Layne M.D., Carvajal I.M., Kritek P.A., Baron R.M., Chen Y.H., Vom Saal J., Levy B.D., Yet S.F., Perrella M.A. Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J. 2003, 17:1325-1327.
24. Elewaut D., DiDonato J.A., Kim J.M., Truong F., Eckmann L, Kagnoff M.F. NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J. Immunol. 1999, 163:1457-1466.
25. Elson C.O., Sartor R.B., Tennyson G.S., Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology 1995, 109:1344-1367.
26. Ernst P.B., Pappo J. T-cell-mediated mucosal immunity in the absence of antibody: lessons from Helicobacter pylori infection. Acta Odontol. Scand. 2001, 59:216-221.
27. Fichorova R.N., Cronin A.O., Lien E., Anderson D.J., Ingalls R.R. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J. Immunol. 2002, 168:2424-2432.
28. + enterotoxigenic Escherichia coli, but adhesion of this bacterium to brush borders does not. Infect. Immun. 1998, 66:4050-4055.
29. Frendéus B., Godaly G., Hang L., Karpman D., Lundstedt A.C., Svanborg C. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J. Exp. Med. 2000, 192:881-890.
30. Gaastra W., Svennerholm A.-M. Colonization factors of human enterotoxigenic Escherichia coli: (ETEC). Trends Microbiol. 1996, 4:444-452.
31. Gionchetti P., Amadini C., Rizzello F., Venturi A., Palmonari V., Morselli C., Romagnoli R., Campieri M. Probiotics-role in inflammatory bowel disease. Dig. Liver Dis. 2002, 34:S58-S62.
32. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
33. Hamlet A., Thoreson A-C, Nilsson O., Svennerholm A-M, Olbe L. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology 1999, 116:259-268.
34. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103.
35. Hemmi H., Kaisho T., Takeda K., Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 2003, 170:3059-3064.
36. Hess C.B., Niesel D.W., Holmgren J., Jonson G., Klimpel G.R. Interferon production by Shigella flexneri-infected fibroblasts depends upon intracellular bacterial metabolism. Infect. Immun. 1990, 58:399-405.
37. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature 1981, 292:413.
38. Holmgren J., Fryklund J., Larsson H. Gamma-interferon-mediated down-regulation of electrolyte secretion by intestinal epithelial cells: A local immune mechanism?. Scand. J. Immunol. 1989, 30:499-503.
39. Holmgren J., Svennerholm A-M Bacterial enteric infections and vaccine development. Gastroenterology Clinics of North America 1992, 283-302. WB Saunders, Baltimore. R.P. McDermott, C.O. Elson (Eds.).
40. Holmgren J., Svennerholm A.-M. Vaccines against diarrheal diseases. Handbook of Experimental Pharmacology, vol. 133, Vaccines 1998, 291-328. Springer-Verlag, Berlin-Heidelberg-New York. H. Wigzell (Ed.).
41. Holmgren J., Bergquist C. Oral B subunit-killed whole cell cholera vaccine. New Generation Vaccines 2004, 499-509. Marcel Dekker, New York. M.M. Levine, J. Kaper, R. Rappuoli, M.A. Liu, M.F. Good (Eds.).
42. Hooper L.V., Gordon J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118.
43. +T cell-mediated pulmonary hyper-inflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 2002, 32:1282-1291.
44. Hughes E.A., Galan J.E. Immune response to Salmonella: location, location, location?. Immunity 2002, 16:325-328.
45. Igietseme J.U. Molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide in vivo. Immunology 1996, 88:1-5.
46. + T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect. Immun. 1994, 62:5195-5197.
47. Ilver D., Arnqvist A., Ogren J., Frick I.M., Kersulyte D., Incecik E.T., Berg D.E., Covacci A., Engstrand L., Boren T. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998, 279:373-377.
48. Inobe J., Slavin A.J., Komagata Y., Chen Y., Liu L., Weiner H.L. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 1998, 28:2780-2790.
49. Johansson T., Schön K., Ward M., Lycke N. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 1997, 65:1032-1044.
50. Kagnoff M.F., Eckmann L. Epithelial cells as sensors for microbial infection. J. Clin. Invest. 1997, 100:6-10.
51. Karlsson K.-A. Animal glycosphingolipids as membrane attachment sites for bacteria. Ann. Rev. Biochem. 1989, 58:309-350.
52. Kim J.M., Kim J.S., Jung H.C., Oh Y.K., Chung H.Y., Lee C.H., Song I.S. Helicobacter pylori infection activates the NF-κB signal pathway to induce iNOS and protect human gastric epithelia cells from apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G1171-G1180.
53. Klemm P., Schembri M.A. Bacterial adhesins: function and structure. Int. J. Med. Microbiol. 2000, 290:27-35.
54. Kopecko D.J., Venkatesan M., Buysse J.M. Basic mechanisms and genetic control of bacterial invasion. Enteric Infection: Mechanisms, Manifestation and Management 1989, 41-63. Chapman and Hall, London. M.J.G. Farthing, G.T. Keusch (Eds.).
55. Kopp E., Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 2003, 15:396-401.
56. Kraehenbuhl J.P., Neutra M.R. Epithelial M cells: differentiation and function. Cell. Dev. Biol. 2000, 16:301-332.
57. Lemaitre B. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
58. Lindholm C., Quiding-Järbrink M., Lönroth H., Hamlet A., Svennerholm A.-M. Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. 1998, 66:5964-5971.
59. Lund B., Lindberg F., Marklund B.-I., Normark S. The PapG protein is the α-D-galactopyranosyl-(1,4)-β-D-galactopy-ranose-binding adhesin of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. USA 1987, 84:5898-5902.
60. high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 2003, 71:1755-1762.
61. high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun. 2004, (in press).
62. Macpherson A., Khoo U.Y., Forgacs I., Philpott-Howard J., Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996, 38:365-375.
63. Macpherson A.J., Gatto D., Sainsbury E., Harriman G.R., Hengartner H., Zinkernagel R.M. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000, 23:2222-2226.
64. Madara J.L., Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 1989, 83:724-727.
65. Madsen K.L. Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse. Clin. Invest. Med. 2001, 24:250-257.
66. Mahon B.P., Sheahan B.J., Griffin F., Murphy G., Mills K.H.G. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-γ receptor or immunoglobulin μ chain genes. J. Exp. Med. 1997, 186:1843-1851.
67. Mastroeni P., Harrison J.A., Robinson J.H., Clare S., Khan S., Maskell D.J., Dougan G., Hormaeche C.E. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect. Immun. 1998, 66:4767-4776.
68. Matzinger P. Tolerance, danger and the extended family. Ann. Rev. Immunol. 1994, 12:809-838.
69. McGuirk P., McCann C., Mills K.H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin-10 production dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 2002, 195:221-231.
70. McSorley S.J., Asch S., Costalonga M., Reinhardt R.L., Jenkins M.K. Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 2002, 16:365-377.
71. Medaglini D., Oggioni M.R., Pozzi G. Vaginal immunization with recombinant gram-positive bacteria. Am. J. Reprod. Immunol. 1997, 39:199-208.
72. Mielcarek N., Riveau G., Remoué F., Antoine R., Capron A., Locht C. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis. Nature Biotechnol. 1998, 5:454-457.
73. Mills K.H.G., Barnard A., Watkins J., Redhead K. Cell mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 1993, 61:399-410.
74. Mohammadi M.S., Czinn S., Redline R, Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant TH1 phenotype and promote a delayed-type response in the stomachs of mice. J. Immunol. 1996, 156:4729-4738.
75. Morrison R.P., Feilzer K., Tumas D.M. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 1995, 63:4661-4668.
76. Mowat A.M.I., Viney J.L. The anatomical basis of intestinal immunity. Immunol. Rev. 1997, 156:145-166.
77. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., Rao A.S., Madara J.L. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000, 289:1560-1563.
78. Nussler A.K., Billiar T.R. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leuk. Biol. 1993, 54:171.
79. Park J.-H., Um J.-I., Jin Lee B.-J., Goh J.-S., Park S.-Y., Kim W.-S., Kim P.-H. Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production. Cell Immunol. 2002, 219:22-27.
80. Peek R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002, 2:28-37.
81. Perry L.L., Feilzer K., Caldwell H.D. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-γ-dependent and -independent pathways. J. Immunol. 1997, 158:3344-3352.
82. Phalipon A., Sansonetti P.J. Microbial-host interactions at mucosal sites. Host response to pathogenic bacteria at mucosal sites. Curr. Top. Microbiol. Immunol. 1999, 236:163-189.
83. Phalipon A., Cardona A., Kraehenbuhl J-P., Edelman L., Sansonetti P.J., Corthésy B. Secretory component: A new role in secretory IgA-mediated immune exclusion in vivo. Immun. 2002, 17:107-115.
84. Purvén M., Lagergrd T. Haemophilus ducreyi, a cytotoxin-producing bacterium. Infect. Immun. 1992, 60:1156-1162.
85. Qadri F., Raqib R., Ahmed F., Rahman T., Wenneras C., Das S.K., Alam N.H., Mathan M.M., Svennerholm A-M. Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol. 2002, 9:221-229.
86. + regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin. Exp. Immunol. 2003, 132:393-400.
87. Raghavan S., Suri-Payer E., Holmgren J. Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CDC4CD25 regulatory T cells. Scand. J. Immunol. 2004, 60:82-88.
88. Ramshaw I.A., Ruby J., Ramsay A.J., Ada G.L., Karupiah G. Expression of cytokines by recombinant vaccinia viruses: A model for studying cytokines in virus infections in vivo. Immunol. Rev. 1992, 127:157-182.
89. Rappuoli R. New and improved vaccines against diphtheria and tetanus. New Generation Vaccines 1997, 417-436. Marcel Dekker, New York. M.M. Levine, G.C. Woodrow, J.B. Kaper, G.S. Cobon (Eds.).
90. Raupach B., Kaufmann S.H. Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain?. Microbes Infect. 2001, 3:1261-1269.
91. Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., Axon A.T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet 1999, 354:635-639.
92. Robbins J.B., Schneerson R., Szu S.C. O-specific poly-saccharide-protein conjugates for prevention of enteric bacterial diseases. New Generation Vaccines 1997, 803-815. M.M. Levine, G.C. Woodrow, J.B. Kaper, G.S. Cobon (Eds.).
93. Robinson J.K., Blanchard T.G., Levine A.D., Emancipator S.N., Lamm M.E. A mucosal IgA-mediated excretory immune system in vivo. J. Immunol. 2001, 166:3688-3692.
94. Rudin A., Johansson E.-L., Bergquist C., Holmgren J. Differential kinetics and distribution of antibodies in serum, and nasal and vaginal secretions after nasal and oral vaccination of humans. Infect. Immun. 1998, 66:3390-3396.
95. Rudin A., Riise G., Berg M., Holmgren J. Antibody responses in lower respiratory and urinary tract after nasal and oral vaccination of humans with cholera toxin B-subunit. Infect. Immun. 1999, 67:2884-2890.
96. Russell M.W., Mestecky J. Humoral immune responses to microbial infections in the genital tract. Microbes Infect. 2002, 4:667-677.
97. Sansonetti P.J. Genetic and molecular basis of epithelial cell invasion by Shigella species. Rev. Infect. Dis. 1991, 13:285-292.
98. Schilling J.D., Martin S.M., Hunstad D.A., Patel K.P., Mulvey M.A., Justice S.S., Lorenz R.G., Hultgren S.J. CD-14- and toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect. Immun. 2003, 71:1470-1480.
99. Schmidtchen A., Frick I.M., Bjorck L. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates anti-bacterial α-defensin. Mol. Microbiol. 2001, 39:708-713.
100. Selsted M.E., Miller S.I., Henschen A.H., Quellette A.J. Enteric defensins: Antibiotic peptide components of intestinal host defense. J. Cell. Biol. 1992, 118:929-936.
101. Shaw D.M., Gaerthe B., Leer R.J., van der Stap J.G., Smittenaar C., Heijne den Bak-Glashouwer M., Thole J.E., Tielen F.J., Pouwels P.H., Havenith C.E. Engineering the microflora to vaccinate the mucosa: serum immuno-globulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunology 2000, 100:510-518.
102. Sidebotham R.L., Batten J.J., Karim Q.N., Spencer J., Baron J.H. Breakdown of gastric mucus in presence of Helicobacter pylori. J. Clin. Pathol. 1991, 44:52-57.
103. Stambach M.N. Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars. Infect. Immun. 1995, 63:3527.
104. Starner T.D., Swords W.E., Apicella M.A., McCray P.B. Susceptibility of non-typeable Haemophilus influenzae to human β defensins is influenced by lipooligosaccharide acylation. Infect. Immunol. 2002, 70:5287-5289.
105. Stephens R.S. Challenge of Chlamydia research. Infect. Agents Dis. 1992, 1:279-293.
106. Strömberg E., Edebo A., Svennerholm A-M., Lindholm C. Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients. Clin. Diagn. Lab. Immunol. 2003, 10:116-124.
107. +T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 1995, 63:3302-3308.
108. Su H., Feilzer K., Caldwell H.D., Morrison R.P. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 1997, 65:1993-1999.
109. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 1997, 159:1739-1745.
110. +T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 1998, 160:1212-1218.
111. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000, 289:1352-1355.
112. Svanborg C., Godaly G., Hedlund M. Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr. Opin. Microbiol. 1999, 2:99-105.
113. Svanborg C., Frendéus B, Godaly G., Hang L., Hedlund M., Wachtler C. Toll-like receptor signalling and chemokine receptor expression influence the severity of urinary tract infection. J. Infect. Dis. 2001, 183:61-65.
114. Tagliabue A., Nencioni L., Villa Z., Keren D.F., Lowell G.H., Braaschi D. Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature 1983, 306:184-186.
115. Tanigawa T., Watanabe T., Hamaguchi M., Sasaki E., Tominaga K., Fujiwara Y., Oshitani N., Matsumoto T., Higuchi K., Arakawa T. Anti-inflammatory effect of two isoforms of cyclooxygenase in Helicobacter pylori-induced gastritis in mice: possible involvement of prostaglandin E2. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 286:G148-G156.
116. Taylor R.K., Miller V.L., Furlong D.B., Mekalanos J.J. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc. Natl. Acad. Sci. USA 1987, 84:2833-2837.
117. Tullus K., Kuhn I., Orskov I., Orskov F., Möllby R. The importance of P- and type 1-fimbriae for the persistence of Escherichia coli in the human gut. Epidemiol. Infect. 1992, 108:415-421.
118. Underhill D.M., Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 2002, 14:103-110.
119. Wallin R.P.A., Lundqvist A., Moré S.H., von Bonin A., Kiessling R., Ljunggren H-G. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 2002, 23:130-135.
120. Van Camp J.M., Tomaselli V., Coran A.G. Bacterial translocation in the neonate. Curr. Opin. Pediatr. 1994, 6:327-333.
121. Weltzin R.A., Lucia Jandris P., Michetti P., Fields B.N., Kraehenbuhl J.P., Neutra M.R. Binding and transepithelial transport of immunoglobulin by intestinal M cells. Demonstration using monoclonal IgA antibodies against enteric viral proteins. J. Cell. Biol. 1989, 108:1673-1685.
122. Willshaw G.A., Scotland S.M., Rowe B. Vero-cytotoxin-producing Escherichia coli. Escherichia coli: Mechanisms of Virulence 1997, 421-448. Cambridge University Press, Cambridge. M. Sussman (Ed.).
123. Wira C.R., Roche M.A., Rossoll R.M. Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation. Endocrinology 2002, 143:2872-2879.
124. Wold A.E. The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora?. Allergy 1998, 53:20-25.
125. + T cells. Immunol. Rev. 1995, 146:223.
126. Yang X., HayGlass K.T., Brunham R.C. Genetically determined differences in IL-10 and IFN-γ responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J. Immunol. 1996, 156:4338.
127. Yrlid U., Svensson M., Kirby A., Wick M.J. Antigen-presenting cells and anti-Salmonella immunity. Microbes Infect 2001, 3:1239-1248.